He received his undergraduate degree from Boston University, graduating cum laude with a Bachelor of Science degree in Business Administration with concentrations in Entrepreneurship and Marketing.

Fremanezumab reduced migraine attacks and depression symptoms in migraine patients with major depressive disorder.

SAN DIEGO -- Administering fecal microbiota via colonoscopy instead of rectally prevented recurrence of Clostridium difficile ...

If consummated, the marriage will also give AbbVie access to Aliada's MODEL platform for delivering large-molecule drugs across the blood-brain barrier (BBB). The Boston biotech said the platform ...

COPD cases are rising in women. Uncover the latest insights to enhance diagnosis and treatment in your women patients.

More dermatology patients are taking the popular drugs, but little is known about the biology of “Ozempic face” or how best ...

Charles River Laboratories International, Inc. today announced that four new directors will join its Board of Directors and that four long-time members of the Board will not seek re-election at the ...

The Boston-based biotech said today that the orally ... for antibody-based therapies from Biogen, Roche/Prothena and AbbVie. Inhibikase Therapeutics is meanwhile running early-stage trials of ...

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies ...

The Hartford Healthcare Fund (I Share) underperformed the S&P Composite 1500 Health Care Index during the quarter. Read more ...